# A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

> **NCT07450911** · PHASE1 · RECRUITING · sponsor: **ReValve Solutions Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** ReValve System

## Key facts

- **NCT ID:** NCT07450911
- **Lead sponsor:** ReValve Solutions Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07450911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07450911, "A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07450911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*